Nucleic Acid Decontamination Reagents Market to Hit US$ 3.61 Billion by 2031, Says Growth Plus Reports

Newark, New Castle, USA, July 03, 2023 (GLOBE NEWSWIRE) — A recent report by Growth Plus Reports estimated the global nucleic acid decontamination reagents market to be worth US$ 1.75 billion in 2022. From 2023 to 2031, market revenue is expected to grow at a CAGR of 8.4%, reaching US$ 3.61 billion. The most successful strategies, market trends, the competitive environment, significant drivers and opportunities, statistical data, market size, and revenue are all included in the report. 

Key Takeaways: 

• The pharmaceutical and biotechnology companies are deriving market revenue growth. 
• The increasing R&D investments are propelling the market revenue expansion.
• North America dominates the global market with the largest revenue share. 

Request a Free Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/nucleic-acid-decontamination-reagents-market/8517

               Nucleic Acid Decontamination Reagents Market Scope

Market Drivers: 
Recent research activities in life science and healthcare drive the growth of global nucleic acid decontamination market revenue. Furthermore, the large market revenue growth is propelled by technological advancements and demand for a highly effective decontamination agent which is faster, reliable, and easier. 

Market Segmentation: 
Growth plus reports have analyzed the global nucleic acid decontamination reagents market from perspectives such as type, end user, and region.

Type Segmentation: 
Based on type, the global nucleic acid decontamination reagents market is segmented into sodium hypochlorite-based, phosphoric acid-based, sodium hydroxide-based, non-enzymatic reagent, and others. 

Sodium hypochlorite-based reagents account for the largest revenue share in the global market. This large revenue share is attributed to the vast use of this reagent as a decontaminant in molecular biology laboratories and its strong oxidizing activity to degrade DNA and RNA molecules effectively. 

End User Segmentation: 
Based on end-user, the global nucleic acid decontamination reagents market is segmented into hospitals, diagnostic laboratories, academic & research institutes, biopharmaceutical companies, and others. 

The hospitals and diagnostic laboratories segment accounts for the largest revenue share in the global market. This large revenue share is attributed to preventing cross-contamination of samples and ensuring accurate test results. Additionally, these reagents are also used in the decontamination of laboratory equipment, such as pipettes, centrifuges, PCR machines, etc. 

Request for Customization –  https://www.growthplusreports.com/inquiry/customization/nucleic-acid-decontamination-reagents-market/8517

Regional Growth Dynamics: 
Based on region, the global nucleic acid decontamination reagents market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 
North America accounts for the largest revenue share in the global market. This significant revenue share is attributed to using nucleic acid decontamination products to remove or inactivate nucleic acids from surfaces, equipment, and reagents to prevent cross-contamination and the presence of market players. 

Competitive Landscape:
The prominent players operating in the global nucleic acid decontamination reagents market are: 

• Thermo Fisher Scientific Inc.
• Novolab Nanjing Vazyme Biotech Co
• Merck Millipore
• Carl Roth
• Decon Labs
• ITW Reagents
• Minerva Biolabs
• Biosan Ltd.
• Kogene Biotech
• MP Biomedicals
• GenDEPOT
• Takara Bio

New product releases and higher R&D spending are two main techniques used by significant players to get a larger market revenue share. Both domestic and international companies manufacturing nucleic acid decontamination reagents are concentrating on launching unique products while expanding their R&D efforts and monitoring the entry of new competitors. 

Recent Developments: 

• In January 2023, Automated sampling began in diagnostic laboratories thanks to the EZ2 Connect MDx IVD platform from Qiagen. Laboratories can simultaneously purify DNA and RNA from up to 24 samples using the highly automated EZ2 Connect MDx equipment in 30 minutes. 

• In October 2021, A non-invasive, chemical-free UVC disinfection system for cleanrooms used in the manufacture of medical devices was introduced by Bio-One Sciences. Its innovative service continually emits UVC rays that quickly and effectively destroy germs and diseases’ Deoxyribonucleic Acid (DNA). 

Table of Content

1. INTRODUCTION
   1. Market Ecosystem
   2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
   3. Currency Used in the Report
2. RESEARCH METHODOLOGY 
   1. Research Approach
   2. Data Collection Methodology
   3. Data Sources
      1. Secondary Sources 
      2. Primary Sources 
   4. Market Estimation Approach
      1. Bottom Up
      2. Top Down 
   5. Market Forecasting Model
   6. Limitations and Assumptions
3. PREMIUM INSIGHTS
   1. Current Market Trends (COVID-19 Perspective)
   2. Key Players & Competitive Positioning (2022) 
   3. Regulatory Landscape
4. MARKET DYNAMICS
   1. Drivers
   2. Restraints/Challenges
   3.  Opportunities
5. GLOBAL NUCLEIC ACID DECONTAMINATION REAGENTS MARKET – ANALYSIS & FORECAST, BY TYPE
   1. Sodium Hypochlorite-Based 
   2. Phosphoric Acid-Based 
   3. Sodium Hydroxide-Based 
   4. Non-Enzymatic Reagent
   5. Others
6. GLOBAL NUCLEIC ACID DECONTAMINATION REAGENTS MARKET – ANALYSIS & FORECAST, BY END USER
   1. Hospitals
   2. Diagnostic Laboratories
   3. Academic & Research Institutes
   4. Biopharmaceutical Companies 
   5. Others

NUCLEIC ACID DECONTAMINATION REAGENTS MARKET TOC

Buy this Premium Research Report: https://www.growthplusreports.com/checkout-8517

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
• Blanket coverage on competitive landscape
• Winning imperatives
• Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market.

CUSTOMIZATION OPTIONS:

• Distributor Landscape Assessment
• Pricing Intelligence
• Customer Base Assessment
• Investment & Initiatives Analysis
• ‘Business Profile’ of Key Players

Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Visit our report store at – https://www.growthplusreports.com/report-store

Browse more latest healthcare reports:

Combination Antihypertensives Market by Type (ACE Inhibitors with Calcium Channel blocking agents, ACE inhibitors with thiazides), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Hydatid Disease Treatment Market by Drug (Mebendazole, Albendazole), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

High-Grade Neuroendocrine Neoplasms Market by Drug Class (Platinum Coordination Complexes, Somatostatin Analogues), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Postoperative Pain Medication Market by Drug Class (NSAIDS, Opioids), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook & Forecast 2023-2031

Mast Cell Stabilizers Market by Type (Mastocytosis, Seasonal Allergic Rhinitis, and Perennial Allergic Conjunctivitis), Distribution Channel (Hospital Pharmacies, Retail Pharmacies) – Global Outlook and Forecast 2023-2031

Unleashing the Power of Innovation in Med Tech:  https://growthplusmedtechroundup.com

About Us:

Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).

Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.

We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.